logo
logo

Jeito Capital Becomes Key Investor In Nmd Pharma As Part Of A €35 Million New Financing

Jeito Capital Becomes Key Investor In Nmd Pharma As Part Of A €35 Million New Financing

02/15/22, 6:00 AM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/FR.svgparis
Money raised
€35 million
Jeito Capital (“Jeito”), a leading independent Private Equity firm dedicated to biotech and biopharma, today announces that it has become a key investor as part of a €35 Million new financing round in NMD Pharma. The Danish biotech company is developing breakthrough therapies for patients suffering from severe neuromuscular disorders.

Company Info

Company
Jeito Capital
Location
paris, ile de france, france